Nephrotoxicity of amphotericin B desoxycholate [1]

Clinical Infectious Diseases

Volumn 33, Issue 6, 2001, Pages 915-916

  Girmenia, C ^a   Gentile, G ^a   Micozzi, A ^a   Martino, P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B DERIVATIVE; AMPHOTERICIN B LIPID COMPLEX; CREATININE; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; CREATININE BLOOD LEVEL; DEHYDRATION; DRUG ACCUMULATION; DRUG FORMULATION; DRUG WITHDRAWAL; HUMAN; LETTER; NEPHROTOXICITY; PRIORITY JOURNAL; SODIUM DEPLETION;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DEOXYCHOLIC ACID; DRUG COMBINATIONS; HUMANS; KIDNEY FAILURE, ACUTE; SAFETY;

EID: 0035884878     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/322716     Document Type: Letter

References (9)

1. Mortality and costs of acute renal failure associated with amphotericin B therapy
2. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia
3. Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis
4. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
5. Amphotericin B use in a community hospital, with special emphasis on side effects
6. Must we really fear toxicity, of conventional amphotericin B in oncological patients?
7. Sodium status influences chronic amphotericin B nephrotoxicity in rats
8. Sodium protects against nephrotoxicity in patients receiving amphotericin B
9. Prevention of amphotericin B-induced renal impairment: A review on the use of sodium supplementation